Cargando…

Correction to: Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study

Detalles Bibliográficos
Autores principales:	Verhagen, Iris E., Brandt, Roemer B., Kruitbosch, Carlijn M. A., MaassenVanDenBrink, Antoinette, Fronczek, Rolf, Terwindt, Gisela M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577000/ https://www.ncbi.nlm.nih.gov/pubmed/34753424 http://dx.doi.org/10.1186/s10194-021-01346-z

Ejemplares similares

Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study
por: Verhagen, Iris E., et al.
Publicado: (2021)

Sex differences in prevalence of migraine trigger factors: A cross-sectional study
por: van Casteren, Daphne S, et al.
Publicado: (2020)

E-diary use in clinical headache practice: A prospective observational study
por: van Casteren, Daphne S, et al.
Publicado: (2021)

The potential danger of blocking CGRP for treating migraine in CADASIL patients
por: de Boer, Irene, et al.
Publicado: (2020)

Validation of diagnostic ICHD-3 criteria for menstrual migraine
por: Verhagen, Iris E, et al.
Publicado: (2022)

Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment
por: MaassenVanDenBrink, Antoinette, et al.
Publicado: (2018)

Comparing Perimenstrual and Nonperimenstrual Migraine Attacks Using an e-Diary
por: van Casteren, Daphne S., et al.
Publicado: (2021)

Jealousy in women with migraine: a cross-sectional case-control study
por: van Casteren, Daphne S., et al.
Publicado: (2020)

Pain perception in women with menstrually-related migraine
por: Linstra, Katie M, et al.
Publicado: (2020)

Serum CGRP in migraine patients using erenumab as preventive treatment
por: de Vries Lentsch, Simone, et al.
Publicado: (2022)

Treatment with the monoclonal calcitonin gene‐related peptide receptor antibody erenumab: A real‐life study
por: de Vries Lentsch, Simone, et al.
Publicado: (2021)

Headache medication and the COVID-19 pandemic
por: MaassenVanDenBrink, Antoinette, et al.
Publicado: (2020)

Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study
por: MaassenVanDenBrink, Antoinette, et al.
Publicado: (2021)

Debate: Are cluster headache and migraine distinct headache disorders?
por: Al-Karagholi, Mohammad Al-Mahdi, et al.
Publicado: (2022)

Gender aspects of CGRP in migraine
por: Labastida-Ramírez, Alejandro, et al.
Publicado: (2017)

Pharmacotherapy for Cluster Headache
por: Brandt, Roemer B., et al.
Publicado: (2020)

Metabolic Aspects of Migraine: Association With Obesity and Diabetes Mellitus
por: Rivera-Mancilla, Eduardo, et al.
Publicado: (2021)

Revisiting dose-finding of monoclonal antibodies in migraine
por: Al-Hassany, Linda, et al.
Publicado: (2023)

Persistent post-traumatic headache: a migrainous loop or not? The preclinical evidence
por: Benemei, Silvia, et al.
Publicado: (2020)

Giving Researchers a Headache – Sex and Gender Differences in Migraine
por: Al-Hassany, Linda, et al.
Publicado: (2020)

Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds
por: Grände, Gustaf, et al.
Publicado: (2014)

European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update
por: Sacco, Simona, et al.
Publicado: (2022)

Blood Pressure in Patients With Migraine Treated With Monoclonal Anti-CGRP (Receptor) Antibodies: A Prospective Follow-up Study
por: de Vries Lentsch, Simone, et al.
Publicado: (2022)

Persistent post-traumatic headache: a migrainous loop or not? The clinical evidence
por: Labastida-Ramírez, Alejandro, et al.
Publicado: (2020)

COVID-19 vaccination-triggered cluster headache episodes with frequent attacks
por: Brandt, Roemer B, et al.
Publicado: (2022)

Position Paper on Post-Traumatic Headache: The Relationship Between Head Trauma, Stress Disorder, and Migraine
por: Lambru, Giorgio, et al.
Publicado: (2020)

Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)
por: Sacco, Simona, et al.
Publicado: (2018)

European headache federation consensus on the definition of resistant and refractory migraine: Developed with the endorsement of the European Migraine & Headache Alliance (EMHA)
por: Sacco, Simona, et al.
Publicado: (2020)

The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse
por: van Hoogstraten, Willem Sebastiaan, et al.
Publicado: (2019)

Measurements of 17β-estradiol levels in mice for migraine research
por: Chan, K, et al.
Publicado: (2013)

PACAP38 and PAC(1) receptor blockade: a new target for headache?
por: Rubio-Beltrán, Eloisa, et al.
Publicado: (2018)

Extracranial Trigger Site Surgery for Migraine: A Systematic Review With Meta-Analysis on Elimination of Headache Symptoms
por: Vincent, Arnaud J. P. E., et al.
Publicado: (2019)

European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 2: flunarizine
por: Deligianni, Christina I., et al.
Publicado: (2023)

Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance
por: Sacco, Simona, et al.
Publicado: (2021)

Sex Differences in Risk Profile, Stroke Cause and Outcome in Ischemic Stroke Patients With and Without Migraine
por: Linstra, Katie M., et al.
Publicado: (2021)

European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate
por: Raffaelli, Bianca, et al.
Publicado: (2023)

17β-estradiol and methylation of migraine-related genes
por: Labruijere, S, et al.
Publicado: (2013)

European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 1: amitriptyline
por: Lampl, Christian, et al.
Publicado: (2023)

Comment on “A second trigeminal CGRP receptor: function and expression of the AMY1 receptor”
por: Haanes, Kristian Agmund, et al.
Publicado: (2016)

Methylation of Migraine-Related Genes in Different Tissues of the Rat
por: Labruijere, Sieneke, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2sae5eoepv6hhj68egjkfk36nl